{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:12:54Z","timestamp":1792242774176,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Phelan-McDermid syndrome (PMS) is caused by monoallelic loss or inactivation at the <jats:italic>SHANK3<\/jats:italic> gene, located in human chr 22q13.33, and is often associated with Autism Spectrum Disorder (ASD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To assess the clinical and developmental phenotype in a novel sample of PMS patients, including for the first time auxometric trajectories and serotonin blood levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>70 Italian PMS patients were clinically characterized by parental report, direct medical observation, and a thorough medical and psychodiagnostic protocol. Serotonin levels were measured in platelet-rich plasma by HPLC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our sample includes 59 (84.3%) cases with chr. 22q13 terminal deletion, 5 (7.1%) disruptive <jats:italic>SHANK3<\/jats:italic> mutations, and 6 (8.6%) ring chromosome 22. Intellectual disability was present in 69 (98.6%) cases, motor coordination disorder in 65 (92.9%), ASD in 20 (28.6%), and lifetime bipolar disorder in 12 (17.1%). Prenatal and postnatal complications were frequent (22.9%-48.6%). Expressive and receptive language were absent in 49 (70.0%) and 19 (27.1%) cases, respectively. Decreased pain sensitivity was reported in 56 (80.0%), hyperactivity in 49 (80.3%), abnormal sleep in 45 (64.3%), congenital dysmorphisms in 35 (58.3%), chronic stool abnormalities and especially constipation in 29 (41.4%). Parents reported noticing behavioral abnormalities during early childhood immediately after an infective episode in 34 (48.6%) patients. Brain MRI anomalies were observed in 53 (79.1%), EEG abnormalities in 16 (23.5%), kidney and upper urinary tract malformations in 18 (28.1%). Two novel phenotypes emerged: (a) a subgroup of 12\/44 (27.3%) PMS patients displays smaller head size at enrollment (mean age 11.8 yrs) compared to their first year of neonatal life, documenting a deceleration of head growth (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001); (b) serotonin blood levels are significantly lower in 21 PMS patients compared to their 21 unaffected siblings (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and to 432 idiopathic ASD cases (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We replicate and extend the description of many phenotypic characteristics present in PMS, and report two novel features: (1) growth trajectories are variable and head growth appears to slow down during childhood in some PMS patients; (2) serotonin blood levels are decreased in PMS, and not increased as frequently occurs in ASD. Further investigations of these novel features are under way.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s11689-024-09572-7","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:03:08Z","timestamp":1727960588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome"],"prefix":"10.1186","volume":"16","author":[{"given":"Lisa","family":"Asta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Ricciardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Boncoddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gnazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scandolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pisan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pelagatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethia","family":"Chehbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Camia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-4479","authenticated-orcid":false,"given":"Antonio M.","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"issue":"3\u20135","key":"9572_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000334260","volume":"2","author":"K Phelan","year":"2011","unstructured":"Phelan K, McDermid HE. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol. 2011;2(3\u20135):186\u2013201.","journal-title":"Mol Syndromol."},{"issue":"1","key":"9572_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1866-1955-6-39","volume":"6","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodevelop Disord. 2014;6(1):39.","journal-title":"J Neurodevelop Disord"},{"issue":"3","key":"9572_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.a.33253","volume":"152","author":"SU Dhar","year":"2010","unstructured":"Dhar SU, Del Gaudio D, German JR, Peters SU, Ou Z, Bader PI, et al. 22q13.3 deletion syndrome: Clinical and molecular analysis using array CGH. Am J Med Genet A. 2010;152(3):573\u201381.","journal-title":"Am J Med Genet A."},{"issue":"1","key":"9572_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2040-2392-4-18","volume":"4","author":"L Soorya","year":"2013","unstructured":"Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013;4(1):18.","journal-title":"Mol Autism"},{"issue":"1","key":"9572_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13229-018-0205-9","volume":"9","author":"S De Rubeis","year":"2018","unstructured":"De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Mol Autism. 2018;9(1):31.","journal-title":"Mol Autism"},{"issue":"9","key":"9572_CR6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.seizure.2014.06.008","volume":"23","author":"MG Figura","year":"2014","unstructured":"Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, et al. Seizures and EEG pattern in the 22q13.3 deletion syndrome: Clinical report of six Italian case. Seizure. 2014;23(9):774\u20139.","journal-title":"Seizure."},{"issue":"1","key":"9572_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13023-020-01592-5","volume":"15","author":"N Xu","year":"2020","unstructured":"Xu N, Lv H, Yang T, Du X, Sun Y, Xiao B, et al. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes. Orphanet J Rare Dis. 2020;15(1):335.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"9572_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/epi.13506","volume":"57","author":"JL Holder","year":"2016","unstructured":"Holder JL, Quach MM. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK 3 loss-of-function mutations. Epilepsia. 2016;57(10):1651\u20139.","journal-title":"Epilepsia"},{"issue":"1","key":"9572_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11689-021-09370-5","volume":"13","author":"M Burdeus-Olavarrieta","year":"2021","unstructured":"Burdeus-Olavarrieta M, San Jos\u00e9-C\u00e1ceres A, Garc\u00eda-Alc\u00f3n A, Gonz\u00e1lez-Pe\u00f1as J, Hern\u00e1ndez-Jusdado P, Parellada-Redondo M. Characterisation of the clinical phenotype in Phelan-McDermid syndrome. J Neurodev Disord. 2021;13(1):26.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9572_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cge.14074","volume":"101","author":"L Jain","year":"2022","unstructured":"Jain L, Oberman LM, Beamer L, Cascio L, May M, Srikanth S, et al. Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures. Clin Genet. 2022;101(1):87\u2013100.","journal-title":"Clin Genet"},{"key":"9572_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2021.06.002","volume":"122","author":"Y Frank","year":"2021","unstructured":"Frank Y. The Neurological Manifestations of Phelan-McDermid Syndrome. Pediatr Neurol. 2021;122:59\u201364.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"9572_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002173","volume":"7","author":"MC Bonaglia","year":"2011","unstructured":"Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, et al. Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan\/McDermid Syndrome. PLoS Genet. 2011Jul;7(7): e1002173.","journal-title":"PLoS Genet"},{"issue":"1","key":"9572_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.a.35700","volume":"161A","author":"KA Aldinger","year":"2013","unstructured":"Aldinger KA, Kogan J, Kimonis V, Fernandez B, Horn D, Klopocki E, et al. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. Am J Med Genet A. 2013;161A(1):131\u20136.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"9572_CR14","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1542\/peds.2007-2584","volume":"122","author":"A Philippe","year":"2008","unstructured":"Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, et al. Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood. Pediatrics. 2008;122(2):e376-82.","journal-title":"Pediatrics."},{"key":"9572_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41525-017-0035-2","volume":"2","author":"AC Tabet","year":"2017","unstructured":"Tabet AC, Rolland T, Ducloy M, L\u00e9vy J, Buratti J, Mathieu A, et al. A framework to identify contributing genes in patients with Phelan-McDermid syndrome. NPJ Genom Med. 2017;2:32.","journal-title":"NPJ Genom Med"},{"issue":"9","key":"9572_CR16","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/ajmg.a.34158","volume":"155","author":"JD Rollins","year":"2011","unstructured":"Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS. Growth in Phelan\u2013McDermid syndrome. Am J Med Genet A. 2011;155(9):2324\u20136.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"9572_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/genes14030540","volume":"14","author":"SM Sarasua","year":"2023","unstructured":"Sarasua SM, DeLuca JM, Rogers C, Phelan K, Rennert L, Powder KE, et al. Head Size in Phelan\u2013McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13. Genes. 2023;14(3):540.","journal-title":"Genes"},{"issue":"3","key":"9572_CR18","first-page":"464","volume":"54","author":"NJ Nesslinger","year":"1994","unstructured":"Nesslinger NJ, Gorski JL, Kurczynski TW, Shapira SK, Siegel-Bartelt J, Dumanski JP, et al. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet. 1994;54(3):464\u201372.","journal-title":"Am J Hum Genet."},{"issue":"4","key":"9572_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ajmg.c.30155","volume":"145","author":"K Cusmano\u2010Ozog","year":"2007","unstructured":"Cusmano\u2010Ozog K, Manning MA, Hoyme HE. 22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay. Am J Med Genet C Semin Med Genet. 2007;145(4):393\u20138.","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"7","key":"9572_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00439-014-1423-7","volume":"133","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan\u2013McDermid syndrome. Hum Genet. 2014;133(7):847\u201359.","journal-title":"Hum Genet"},{"issue":"1","key":"9572_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2040-2392-4-17","volume":"4","author":"C Betancur","year":"2013","unstructured":"Betancur C, Buxbaum JD. SHANK3 haploinsufficiency: a \u201ccommon\u201d but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Mol Autism. 2013;4(1):17.","journal-title":"Mol Autism"},{"issue":"1","key":"9572_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-019-9273-1","volume":"11","author":"CI Samogy-Costa","year":"2019","unstructured":"Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. J Neurodev Disord. 2019;11(1):13.","journal-title":"J Neurodev Disord"},{"key":"9572_CR23","unstructured":"Phelan-McDermid Syndrome - Symptoms, Causes, Treatment | NORD. https:\/\/rarediseases.org\/rare-diseases\/phelan-mcdermid-syndrome\/.\u00a0Accessed 15 Jan 2024."},{"key":"9572_CR24","unstructured":"PMSF By The Numbers. Phelan-McDermid Syndrome Foundation. https:\/\/pmsf.org\/pmsf-by-the-numbers\/ Accessed 15 Jan 2024."},{"issue":"2","key":"9572_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/321293","volume":"69","author":"MC Bonaglia","year":"2001","unstructured":"Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O. Disruption of the ProSAP2 Gene in a t(12;22)(q24.1;q13.3) Is Associated with the 22q13.3 Deletion Syndrome. Am J Hum Genet. 2001;69(2):261\u20138.","journal-title":"Am J Hum Genet."},{"issue":"40","key":"9572_CR26","doi-asserted-by":"publisher","first-page":"34839","DOI":"10.1074\/jbc.M111.258384","volume":"286","author":"C Verpelli","year":"2011","unstructured":"Verpelli C, Dvoretskova E, Vicidomini C, Rossi F, Chiappalone M, Schoen M, et al. Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses. J Biol Chem. 2011;286(40):34839\u201350.","journal-title":"J Biol Chem"},{"issue":"1","key":"9572_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-015-0323-9","volume":"10","author":"LM Oberman","year":"2015","unstructured":"Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet J Rare Dis. 2015;10(1):105.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"9572_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jmedgenet-2011-100225","volume":"48","author":"SM Sarasua","year":"2011","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2011;48(11):761\u20136.","journal-title":"J Med Genet"},{"issue":"4","key":"9572_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/gim.2013.144","volume":"16","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Dwivedi A, Boccuto L, Chen CF, Sharp JL, Rollins JD, et al. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan\u2013McDermid syndrome. Genet Med. 2014;16(4):318\u201328.","journal-title":"Genet Med."},{"issue":"4","key":"9572_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddab280","volume":"31","author":"T Levy","year":"2022","unstructured":"Levy T, Foss-Feig JH, Betancur C, Siper PM, Trelles-Thorne MDP, Halpern D, et al. Strong evidence for genotype\u2013phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum Mol Genet. 2022;31(4):625\u201337.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9572_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/cge.14364","volume":"104","author":"MS Smith","year":"2023","unstructured":"Smith MS, Sarasua SM, Rogers C, Phelan K, Boccuto L. Lymphedema is associated with CELSR1 in Phelan-McDermid syndrome. Clin Genet. 2023;104(4):472\u20138.","journal-title":"Clin Genet"},{"issue":"7","key":"9572_CR32","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/ajmg.a.62222","volume":"185","author":"A Ricciardello","year":"2021","unstructured":"Ricciardello A, Tomaiuolo P, Persico AM. Genotype\u2013phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes. Am J Med Genet A. 2021;185(7):2211\u201333.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9572_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13023-022-02180-5","volume":"17","author":"K Phelan","year":"2022","unstructured":"Phelan K, Boccuto L, Powell CM, Boeckers TM, van Ravenswaaij-Arts C, Rogers RC, et al. Phelan-McDermid syndrome: a classification system after 30 years of experience. Orphanet J Rare Dis. 2022;17(1):27.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"9572_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/dneu.22128","volume":"74","author":"A Guilmatre","year":"2014","unstructured":"Guilmatre A, Huguet G, Delorme R, Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. Dev Neurobiol. 2014;74(2):113\u201322.","journal-title":"Dev Neurobiol"},{"issue":"6","key":"9572_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s10571-021-01054-x","volume":"42","author":"L Wan","year":"2022","unstructured":"Wan L, Liu D, Xiao WB, Zhang BX, Yan XX, Luo ZH, Xiao B. Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries. Cell Mol Neurobiol. 2022;42(6):1623\u201343.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"9572_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ejhg.2012.175","volume":"21","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet. 2013;21(3):310\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"9572_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1542\/peds.114.2.451","volume":"114","author":"MA Manning","year":"2004","unstructured":"Manning MA, Cassidy SB, Clericuzio C, Cherry AM, Schwartz S, Hudgins L, et al. Terminal 22q Deletion Syndrome: A Newly Recognized Cause of Speech and Language Disability in the Autism Spectrum. Pediatrics. 2004;114(2):451\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"9572_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.braindev.2012.05.013","volume":"35","author":"S Uchino","year":"2013","unstructured":"Uchino S, Waga C. SHANK3 as an autism spectrum disorder-associated gene. Brain Dev. 2013;35(2):106\u201310.","journal-title":"Brain Dev"},{"issue":"9","key":"9572_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004580","volume":"10","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, et al. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments. PLoS Genet. 2014;10(9): e1004580.","journal-title":"PLoS Genet"},{"issue":"3","key":"9572_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.b.30822","volume":"150B","author":"J Gauthier","year":"2009","unstructured":"Gauthier J, Spiegelman D, Piton A, Lafreni\u00e8re RG, Laurent S, St-Onge J, et al. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(3):421\u20134.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"9572_CR41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/522590","volume":"81","author":"R Moessner","year":"2007","unstructured":"Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007;81(6):1289\u201397.","journal-title":"Am J Hum Genet"},{"key":"9572_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/NDT.S30506","volume":"8","author":"WM Verhoeven","year":"2012","unstructured":"Verhoeven WM, Egger JI, Willemsen MH, de Leijer GJ, Kleefstra T. Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype? Neuropsychiatr Dis Treat. 2012;8:175\u20139.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"9572_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000339119","volume":"3","author":"A Denayer","year":"2012","unstructured":"Denayer A, Van Esch H, de Ravel T, Frijns JP, Van Buggenhout G, Vogels A, et al. Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills. Mol Syndromol. 2012;3(1):14\u201320.","journal-title":"Mol Syndromol"},{"issue":"1","key":"9572_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13229-019-0291-3","volume":"10","author":"A Kolevzon","year":"2019","unstructured":"Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Mol Autism. 2019;10(1):50.","journal-title":"Mol Autism"},{"issue":"17","key":"9572_CR45","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1073\/pnas.0906232107","volume":"107","author":"J Gauthier","year":"2010","unstructured":"Gauthier J, Champagne N, Lafreni\u00e8re RG, Xiong L, Spiegelman D, Brustein E, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA. 2010;107(17):7863\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9572_CR46","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajmg.b.32528","volume":"174","author":"CA De Sena","year":"2017","unstructured":"De Sena CA, Degenhardt F, Strohmaier J, Lang M, Weiss B, Roeth R, et al. Investigation of SHANK3 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2017;174(4):390\u20138.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"9572_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s11689-021-09398-7","volume":"13","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Condy E, Carmody E, Filip-Dhima R, Kapur K, Bernstein JA, et al. Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome. J Neurodev Disord. 2021;13(1):53.","journal-title":"J Neurodev Disord"},{"issue":"11","key":"9572_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrn.2017.112","volume":"18","author":"CE Robertson","year":"2017","unstructured":"Robertson CE, Baron-Cohen S. Sensory perception in autism. Nat Rev Neurosci. 2017;18(11):671\u201384.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"9572_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5014\/ajot.61.2.190","volume":"61","author":"SD Tomchek","year":"2007","unstructured":"Tomchek SD, Dunn W. Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther. 2007;61(2):190\u2013200.","journal-title":"Am J Occup Ther"},{"key":"9572_CR50","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, American Psychiatric Association, eds. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"7","key":"9572_CR51","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1007\/s10803-016-2754-0","volume":"46","author":"AM Mieses","year":"2016","unstructured":"Mieses AM, Tavassoli T, Li E, Soorya L, Lurie S, Wang AT, et al. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome. J Autism Dev Disord. 2016;46(7):2508\u201313.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"9572_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-016-9150-0","volume":"8","author":"RJ Zwanenburg","year":"2016","unstructured":"Zwanenburg RJ, Ruiter SA, van den Heuvel ER, Flapper BCT, Van Ravenswaaij-Arts CM. Developmental phenotype in Phelan-McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children. J Neurodev Disord. 2016;8(1):16.","journal-title":"J Neurodev Disord."},{"key":"9572_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.893003","volume":"16","author":"S Serrada-Tejeda","year":"2022","unstructured":"Serrada-Tejeda S, Mart\u00ednez-Pi\u00e9drola RM, M\u00e1ximo-Bocanegra N, S\u00e1nchez-Herrera-Baeza P, P\u00e9rez-de-Heredia-Torres M. Descriptive Analysis of Adaptive Behavior in Phelan-McDermid Syndrome and Autism Spectrum Disorder. Front Neurosci. 2022;16: 893003.","journal-title":"Front Neurosci"},{"issue":"7","key":"9572_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/dmcn.15482","volume":"65","author":"Y Dille","year":"2023","unstructured":"Dille Y, Lagae L, Swillen A, Buggenhout GV. Neurodevelopmental profile and stages of regression in Phelan\u2013McDermid syndrome. Dev Med Child Neurol. 2023;65(7):917\u201325.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"9572_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11689-020-9309-6","volume":"12","author":"TM Kohlenberg","year":"2020","unstructured":"Kohlenberg TM, Trelles MP, McLarney B, Betancur C, Thurm A, Kolevzon A. Psychiatric illness and regression in individuals with Phelan-McDermid syndrome. J Neurodev Disord. 2020;12(1):7.","journal-title":"J Neurodev Disord"},{"key":"9572_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.03.010","volume":"91","author":"G Reierson","year":"2017","unstructured":"Reierson G, Bernstein J, Froehlich-Santino W, Urban A, Purmann C, Berquist S, et al. Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome). J Psychiatr Res. 2017;91:139\u201344.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"9572_CR57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/YCO.0000000000000672","volume":"34","author":"A Vogels","year":"2021","unstructured":"Vogels A, Droogmans G, Vergaelen E, Van Buggenhout G, Swillen A. Recent developments in Phelan\u2013McDermid syndrome research: an update on cognitive development, communication and psychiatric disorders. Curr Opin Psychiatry. 2021;34(2):118\u201322.","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"9572_CR58","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","volume":"24","author":"S Gabriele","year":"2014","unstructured":"Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24(6):919\u201329.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"9572_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2040-2392-4-29","volume":"4","author":"S Tordjman","year":"2013","unstructured":"Tordjman S, Anderson GM, Cohen D, Kermarrec S, Carlier M, Touitou Y, et al. Presence of autism, hyperserotonemia, and severe expressive language impairment in Williams-Beuren syndrome. Mol Autism. 2013;4(1):29.","journal-title":"Mol Autism"},{"key":"9572_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.677563","volume":"15","author":"SE Stilley","year":"2021","unstructured":"Stilley SE, Blakely RD. Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse. Front Cell Neurosci. 2021;15: 677563.","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"9572_CR61","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A. 2012;109(14):5469\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9572_CR62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/aur.151","volume":"3","author":"R Sacco","year":"2010","unstructured":"Sacco R, Curatolo P, Manzi B, Militerni R, Bravaccio C, Frolli A, et al. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res. 2010;3:237\u201352.","journal-title":"Autism Res"},{"issue":"3","key":"9572_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0006-3223(92)90106-A","volume":"32","author":"J John Mann","year":"1992","unstructured":"John Mann J, Anne McBride P, Anderson GM, Mieczkowski TA. Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and life-time psychopathology. Biol Psychiatry. 1992;32(3):243\u201357.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"9572_CR64","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.psychres.2014.09.018","volume":"220","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Lim T, Schmeidler J, Martello T, Cook EH Jr, Silverman JM. Self-injury in autism spectrum disorder: An effect of serotonin transporter gene promoter variants. Psychiatry Res. 2014;220(3):987\u201390.","journal-title":"Psychiatry Res"},{"key":"9572_CR65","doi-asserted-by":"crossref","unstructured":"Lord C, Luyster RJ, Gotham K, Guthrie W. Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Manual (Part II): Toddler Module. Torrance, CA: Western Psychological Services; 2012.","DOI":"10.1007\/978-1-4419-1698-3_2011"},{"issue":"5","key":"9572_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659\u201385.","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"9572_CR67","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10803-006-0213-z","volume":"37","author":"KSL Lam","year":"2007","unstructured":"Lam KSL, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. J Autism Dev Disord. 2007;37(5):855\u201366.","journal-title":"J Autism Dev Disord"},{"key":"9572_CR68","first-page":"59","volume-title":"Sensory Profile: User's Manual","author":"DN McIntosh","year":"1999","unstructured":"McIntosh DN, Miller LJ, Shyu V. Development and validation of the Short Sensory profile. In: Dunn W, editor. Sensory Profile: User\u2019s Manual. Psychological Corporation (San Francisco, CA); 1999. p. 59\u201373."},{"issue":"5","key":"9572_CR69","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89(5):485\u201391.","journal-title":"Am J Ment Defic"},{"key":"9572_CR70","unstructured":"Achenbach TM. The Child Behavior Checklist and related instruments. In: The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 2nd Ed. Mahwah, NJ: Lawrence Erlbaum Associates Publishers; 1999. p. 429\u201366."},{"key":"9572_CR71","unstructured":"Achenbach TM, Rescorla L. Manual for the ASEBA School-Age Forms & Profiles: An Integrated System of Multi-Informant Assessment. Burlington, VT: ASEBA; 2001."},{"key":"9572_CR72","doi-asserted-by":"crossref","unstructured":"Sparrow SS, Cicchetti DV, Bella DA. Vineland-II Adaptive Behavior Scales. Second Edition. Bloomington, MN: NCS Pearson Inc; 2005.","DOI":"10.1037\/t15164-000"},{"key":"9572_CR73","unstructured":"Griffiths R. The Abilities of Young Children: A Comprehensive System of Mental Measurement for the First Eight Years of Life. Revised Edition. Oxford: A.R.C.I.D. Test Agency Limited; 1984."},{"key":"9572_CR74","doi-asserted-by":"crossref","unstructured":"Wechsler D. Wechsler Intelligence Scale for Children \u2013 Fourth Edition (WISC-IV). San Antonio, TX: The Psychological Corporation; 2003.","DOI":"10.1037\/t15174-000"},{"key":"9572_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-319-50604-3_8","volume-title":"Handbook of Nonverbal Assessment","author":"GH Roid","year":"2017","unstructured":"Roid GH, Koch C. Leiter-3: Nonverbal Cognitive and Neuropsychological Assessment. In: McCallum RS, editor. Handbook of Nonverbal Assessment. Springer International Publishing; 2017. p. 127\u201350."},{"issue":"5","key":"9572_CR76","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s10803-017-3402-z","volume":"48","author":"H McConachie","year":"2018","unstructured":"McConachie H, Mason D, Parr JR, Garland D, Wilson C, Rodgers J. Enhancing the Validity of a Quality of Life Measure for Autistic People. J Autism Dev Disord. 2018;48(5):1596\u2013611.","journal-title":"J Autism Dev Disord"},{"key":"9572_CR77","doi-asserted-by":"publisher","unstructured":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551\u20138. https:\/\/doi.org\/10.1017\/s0033291798006667.","DOI":"10.1017\/s0033291798006667"},{"issue":"1","key":"9572_CR78","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02206997","volume":"21","author":"J Piven","year":"1991","unstructured":"Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21(1):51\u20139.","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"9572_CR79","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pscychresns.2015.08.016","volume":"234","author":"R Sacco","year":"2015","unstructured":"Sacco R, Gabriele S, Persico AM. Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis. Psychiatry Res. 2015;234(2):239\u201351.","journal-title":"Psychiatry Res"},{"key":"9572_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13229-018-0250-4","volume":"10","author":"DM James","year":"2019","unstructured":"James DM, Kozol RA, Kajiwara Y, Wahl AL, Storrs EC, Buxbaum JD, et al. Intestinal dysmotility in a zebrafish (Danio rerio) shank3a;shank3b mutant model of autism. Mol Autism. 2019;10:3.","journal-title":"Mol Autism"},{"key":"9572_CR81","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fnins.2016.00564","volume":"10","author":"A Linan-Rico","year":"2016","unstructured":"Linan-Rico A, Ochoa-Cortes F, Beyder A, Soghomonyan S, Zuleta-Alarcon A, Coppola V, Christofi FL. Mechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut Inflammation. Front Neurosci. 2016;10:564.","journal-title":"Front Neurosci"},{"key":"9572_CR82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4682-5-10","volume":"5","author":"S Janusonis","year":"2008","unstructured":"Janusonis S. Origin of the blood hyperserotonemia of autism. Theor Biol Med Model. 2008;5:10.","journal-title":"Theor Biol Med Model"},{"issue":"7","key":"9572_CR83","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/hmg\/ddy421","volume":"28","author":"S Gabriele","year":"2019","unstructured":"Gabriele S, Canali M, Lintas C, Sacco R, Tirindelli MC, Ricciardello A, Persico AM. Evidence that ITGB3 promoter variants increase serotonin blood levels by regulating platelet serotonin transporter trafficking. Hum Mol Genet. 2019;28(7):1153\u201361.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9572_CR84","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201456","volume":"6","author":"G Hayot","year":"2022","unstructured":"Hayot G, Massonot M, Keime C, Faure E, Golzio C. Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance. Life Sci Alliance. 2022;6(1): e202201456.","journal-title":"Life Sci Alliance"},{"key":"9572_CR85","doi-asserted-by":"publisher","unstructured":"McCluskey KE, Stovell KM, Law K, Kostyanovskaya E, Schmidt J, Exner CRT, et al. Autism gene variants disrupt enteric neuron migration and cause gastrointestinal dysmotility. bioRxiv. 2024:2024.05.28.593642. https:\/\/doi.org\/10.1101\/2024.05.28.593642.","DOI":"10.1101\/2024.05.28.593642"},{"issue":"6","key":"9572_CR86","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1172\/JCI84877","volume":"126","author":"KG Margolis","year":"2016","unstructured":"Margolis KG, Li Z, Stevanovic K, Saurman V, Israelyan N, Anderson GM, et al. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J Clin Invest. 2016;126(6):2221\u201335.","journal-title":"J Clin Invest"},{"issue":"3","key":"9572_CR87","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s10803-015-2646-8","volume":"46","author":"S Marler","year":"2016","unstructured":"Marler S, Ferguson BJ, Lee EB, Peters B, Williams KC, McDonnell E, et al. Brief Report: Whole Blood Serotonin Levels and Gastrointestinal Symptoms in Autism Spectrum Disorder. J Autism Dev Disord. 2016;46(3):1124\u201330.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"9572_CR88","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3906\/sag-1507-68","volume":"46","author":"S Kheirouri","year":"2016","unstructured":"Kheirouri S, Kalejahi P, Noorazar SG. Plasma levels of serotonin, gastrointestinal symptoms, and sleep problems in children with autism. Turk J Med Sci. 2016;46(6):1765\u201372.","journal-title":"Turk J Med Sci"},{"key":"9572_CR89","doi-asserted-by":"publisher","unstructured":"Meng J, Zhang L, Zhang YW. Microglial Dysfunction in Autism Spectrum Disorder. Neuroscientist. 2024 May 7:10738584241252576. https:\/\/doi.org\/10.1177\/10738584241252576. Epub ahead of print.","DOI":"10.1177\/10738584241252576"},{"key":"9572_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110029","volume":"257","author":"H Jiao","year":"2024","unstructured":"Jiao H, Kalsbeek A, Yi CX. Microglia, circadian rhythm and lifestyle factors. Neuropharmacology. 2024;257: 110029.","journal-title":"Neuropharmacology"},{"issue":"10","key":"9572_CR91","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/gm102","volume":"1","author":"LS Carroll","year":"2009","unstructured":"Carroll LS, Owen MJ. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med. 2009;1(10):102. https:\/\/doi.org\/10.1186\/gm102.","journal-title":"Genome Med"},{"issue":"3","key":"9572_CR92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/ijms18030527","volume":"18","author":"NS Khanzada","year":"2017","unstructured":"Khanzada NS, Butler MG, Manzardo AM. GeneAnalytics Pathway Analysis and Genetic Overlap among Autism Spectrum Disorder, Bipolar Disorder and Schizophrenia. Int J Mol Sci. 2017;18(3):527. https:\/\/doi.org\/10.3390\/ijms18030527.","journal-title":"Int J Mol Sci"},{"key":"9572_CR93","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.mcn.2018.02.010","volume":"88","author":"KS O'Connell","year":"2018","unstructured":"O\u2019Connell KS, McGregor NW, Lochner C, Emsley R, Warnich L. The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder. Mol Cell Neurosci. 2018;88:300\u20137. https:\/\/doi.org\/10.1016\/j.mcn.2018.02.010.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"9572_CR94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00467-023-06146-y","volume":"39","author":"MD McCoy","year":"2024","unstructured":"McCoy MD, Sarasua SM, DeLuca JM, Davis S, Rogers RC, Phelan K, Boccuto L. Genetics of kidney disorders in Phelan-McDermid syndrome: evidence from 357 registry participants. Pediatr Nephrol. 2024;39(3):749\u201360.","journal-title":"Pediatr Nephrol"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-024-09572-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-024-09572-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-024-09572-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:03:24Z","timestamp":1727960604000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-024-09572-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9572"],"URL":"https:\/\/doi.org\/10.1186\/s11689-024-09572-7","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of University \u2018\u2018Campus Bio-Medico\u2019\u2019 of Rome, Italy (prot. n. 14\/98, first approval on April 28, 1998 and subsequent amendments) and the Ethics Committee of Messina, Italy (prot. n. 22\/17, approved on June 19, 2017). Written informed consent was obtained from caregivers of all participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}